Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction
Recruiting
Observational Study
Acute Myocardial Infarction With ST Elevation
Intelligent Management Platform
Early Warning
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,400 (estimated)
- Sponsor
- Hui Chen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to learn about the effectiveness of an artificial intelligence-based early warning system for predicting adverse events in patients with acute myocardial infarction (AMI). The main question it aims to answer is:
Does an AI-based early warning system improve the assessment and prediction of adverse events across the full course of AMI care (from prevention t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1\. Hospitalized patients who meet the diagnostic criteria for acute myocardial infarction. 2. Patients who agree to participate and sign the informed consent form.
Exclusion Criteria:
* 1\. Patients with terminal malignant tumors and an expected survival time of less than 3…
Contacts